Why have Pro Medicus shares hit a record high on Monday?

This popular tech stock is scaling new heights on Monday.

| More on:
A group of people in a corporate setting do a collective high five.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Pro Medicus Limited (ASX: PME) shares have started the week positively.

In fact, the health imaging technology company's shares have climbed to a record high of $88.69.

Why are Pro Medicus shares rising?

The catalyst for this rise has been the release of the company's annual general meeting update this morning.

Ahead of the event, Pro Medicus released a presentation that spoke positively about both its performance in the first quarter and its outlook.

In respect to the first quarter, the company revealed that it is "ahead of budget on constant currency."

It also highlights that, as we have covered previously, it has achieved a "record level of contract wins in the first 5 months" of the financial year. A total of $200 million will be generated from these contracts at a minimum.

Management also notes that these "contract wins span multiple market segments" which reinforces its large total addressable market.

Pleasingly, despite its record contract wins, it still has a strong pipeline across a broad range of opportunities. Furthermore, it is strategically positioned to leverage artificial intelligence and other ologies.

Commenting on FY 2024, Pro Medicus' chair, Peter Kempen, said:

The budget for the current financial year has been determined recognising anticipated continuing strong growth, from both existing and new clients. I am pleased to advise that results to date are ahead of budget on a constant currency basis and further ahead with the impact of a lower Australian dollar, relative to the US dollar. We anticipate that the second half of the financial year will be stronger than the first half, as is traditionally the case.

Looking further ahead, Kempen is very positive on the company's medium-term outlook. He adds:

As I mentioned at last year's AGM the Company has adopted a new strategic plan for FY24-FY26 which sets our objectives and our strategies for the next three years. The Board and management have set aggressive growth targets in keeping with the Company's current and potential opportunities. We are in the process of progressively implementing our plans to achieve our next growth phase. We are all committed to achieving further successful outcomes envisaged within the new strategic plan.

Pro Medicus shares are up over 50% on a 12-month basis.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A businessman stacks building blocks.
Technology Shares

6% gain! What's up with Block shares today?

Block shares are up more than 34% since 2 May.

Read more »

Happy work colleagues give each other a fist pump.
Technology Shares

Guess which ASX 200 technology stock has outperformed Nvidia over the past 5 years?

This company has been nothing short of impressive.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Technology Shares

After surging 13% yesterday, are TechnologyOne shares a buy, hold or sell according to Macquarie?

Valuations matter when investing, and Macquarie feels no different.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Technology Shares

Why Goldman Sachs rates this ASX tech share as a top buy

Let's see why the broker rates this stock highly right now.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Technology Shares

WiseTech shares have surged 34% since April. Is it too late to buy?

Can WiseTech shares keep charging higher? Here’s what this investing expert expects.

Read more »

A man in full American NFL playing kit crouches over with his arms across his chest in a defensive stance against a dark background.
Technology Shares

ASX 300 tech stock charges 7% higher to record high on stellar results

This tech stock delivered another impressive result this morning.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Technology Shares

Up 87% in 12 months: Why this ASX tech share is still a top buy

This technology business still has loads of potential, according to a fund manager.

Read more »

a group of three cybersecurity experts stand with satisfied looks on their faces with one holding a laptop computer while he group stands in front of a large bank of computers and electronic equipment.
Technology Shares

2 ASX 200 tech stocks Morgans rates as buys

The leading broker has named a couple of shares to buy right now.

Read more »